daunorubicin has been researched along with Aneuploid in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (66.67) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacher, U; Bokemeyer, C; Fiedler, W; Haalck, T; Janjetovic, S; Janning, M | 1 |
Alexander, HD; Humphreys, MW; Kettle, PJ; McGrattan, P | 1 |
Ferrer-Miralles, N; Mansilla, S; Portugal, J; Priebe, W; VillamarĂn, S | 1 |
Cunningham, MT; Davis, MK; Imkie, M; Persons, DL | 1 |
Hirokawa, M; Horiuchi, T; Kameoka, J; Miura, I; Miyamura, K; Nomura, J; Okuda, M; Sasaki, T; Sawada, K | 1 |
Marinello, MJ; Pothier, L; Preisler, HD; Reese, PA | 1 |
Lorsbach, RB; Mathew, S; Raimondi, SC; Sandlund, JT; Shearer, P | 1 |
Diaz, MA; Garcia-Sanchez, F; Madero, L; Martinez, P; Ruano, D; Tutor, O | 1 |
Adamson, JW; Leventhal, BG; Perry, S; Whang-Peng, J | 1 |
1 review(s) available for daunorubicin and Aneuploid
Article | Year |
---|---|
Tetrasomy 13 as the sole cytogenetic abnormality in acute myeloid leukemia M1 without maturation.
Topics: Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 13; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Thioguanine; Vidarabine | 2002 |
8 other study(ies) available for daunorubicin and Aneuploid
Article | Year |
---|---|
Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.
Topics: Adult; Aneuploidy; Cytarabine; Daunorubicin; DNA Repair; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Neoadjuvant Therapy; Recurrence; Remission Induction; Transplantation, Homologous; Vidarabine; Xeroderma Pigmentosum | 2013 |
A comparative analysis of the time-dependent antiproliferative effects of daunorubicin and WP631.
Topics: Aneuploidy; Antibiotics, Antineoplastic; Apoptosis; Blotting, Western; Colony-Forming Units Assay; Daunorubicin; DNA Adducts; Flow Cytometry; G2 Phase; Humans; Jurkat Cells; Microscopy, Confocal; Microscopy, Phase-Contrast; Mitosis; T-Lymphocytes; Time Factors; Tumor Suppressor Protein p53 | 2003 |
Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation.
Topics: Adult; Aneuploidy; Antigens, CD; Antigens, CD7; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; CD56 Antigen; Cell Size; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; DNA, Neoplasm; Fatal Outcome; Humans; Immunophenotyping; Leukemia, Myeloid, Acute; Male; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous | 2004 |
[Acute monoblastic leukemia with tetrasomy 8].
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cytarabine; Daunorubicin; Fatal Outcome; Female; Humans; Karyotyping; Leukemia, Monocytic, Acute; Peripheral Blood Stem Cell Transplantation | 2006 |
Adverse effects of aneuploidy on the outcome of remission induction therapy for acute nonlymphocytic leukaemia: analysis of types of treatment failure.
Topics: Acute Disease; Aneuploidy; Bone Marrow; Cytarabine; Daunorubicin; Doxorubicin; Drug Therapy, Combination; Female; Humans; Karyotyping; Leukemia; Male; Metaphase; Middle Aged; Prognosis | 1983 |
Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia.
Topics: Anemia, Refractory, with Excess of Blasts; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromosomes, Human, Pair 8; Cladribine; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Fatal Outcome; Female; Gene Amplification; Genes, myc; Humans; Hydrocortisone; Karyotyping; Mercaptopurine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine | 2000 |
Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
Topics: Adolescent; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Bone Marrow; Child; Child, Preschool; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Genes, Immunoglobulin; Humans; Immunoglobulin Heavy Chains; Immunophenotyping; Infant; Leukocyte Count; Male; Neoplasm Proteins; Neoplasm, Residual; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Treatment Outcome; Vincristine | 2000 |
The effect of daunomycin on human cells in vivo and in vitro.
Topics: Aneuploidy; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Culture Techniques; Daunorubicin; DNA, Neoplasm; Humans; Karyotyping; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocytes; RNA, Neoplasm | 1969 |